236 related articles for article (PubMed ID: 35620468)
1. Multi-Omic Data Improve Prediction of Personalized Tumor Suppressors and Oncogenes.
Sudhakar M; Rengaswamy R; Raman K
Front Genet; 2022; 13():854190. PubMed ID: 35620468
[TBL] [Abstract][Full Text] [Related]
2. Novel ratio-metric features enable the identification of new driver genes across cancer types.
Sudhakar M; Rengaswamy R; Raman K
Sci Rep; 2022 Jan; 12(1):5. PubMed ID: 34997044
[TBL] [Abstract][Full Text] [Related]
3. Machine Learning Classification and Structure-Functional Analysis of Cancer Mutations Reveal Unique Dynamic and Network Signatures of Driver Sites in Oncogenes and Tumor Suppressor Genes.
Agajanian S; Odeyemi O; Bischoff N; Ratra S; Verkhivker GM
J Chem Inf Model; 2018 Oct; 58(10):2131-2150. PubMed ID: 30253099
[TBL] [Abstract][Full Text] [Related]
4. Cancer driver mutation prediction through Bayesian integration of multi-omic data.
Wang Z; Ng KS; Chen T; Kim TB; Wang F; Shaw K; Scott KL; Meric-Bernstam F; Mills GB; Chen K
PLoS One; 2018; 13(5):e0196939. PubMed ID: 29738578
[TBL] [Abstract][Full Text] [Related]
5. DORGE: Discovery of Oncogenes and tumoR suppressor genes using Genetic and Epigenetic features.
Lyu J; Li JJ; Su J; Peng F; Chen YE; Ge X; Li W
Sci Adv; 2020 Nov; 6(46):. PubMed ID: 33177077
[TBL] [Abstract][Full Text] [Related]
6. Identifying cancer type specific oncogenes and tumor suppressors using limited size data.
Pavel AB; Vasile CI
J Bioinform Comput Biol; 2016 Dec; 14(6):1650031. PubMed ID: 27712196
[TBL] [Abstract][Full Text] [Related]
7. A novel hypergraph model for identifying and prioritizing personalized drivers in cancer.
Zhang N; Ma F; Guo D; Pang Y; Wang C; Zhang Y; Zheng X; Wang M
PLoS Comput Biol; 2024 Apr; 20(4):e1012068. PubMed ID: 38683860
[TBL] [Abstract][Full Text] [Related]
8. driveR: a novel method for prioritizing cancer driver genes using somatic genomics data.
Ülgen E; Sezerman OU
BMC Bioinformatics; 2021 May; 22(1):263. PubMed ID: 34030627
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of driver genes with tumor suppressive and oncogenic roles in gastric cancer.
Wang T; Liu Y; Zhao M
PeerJ; 2017; 5():e3585. PubMed ID: 28729958
[TBL] [Abstract][Full Text] [Related]
10. A Novel Method for Identifying the Potential Cancer Driver Genes Based on Molecular Data Integration.
Zhang W; Wang SL
Biochem Genet; 2020 Feb; 58(1):16-39. PubMed ID: 31115714
[TBL] [Abstract][Full Text] [Related]
11. Somatic selection distinguishes oncogenes and tumor suppressor genes.
Chandrashekar P; Ahmadinejad N; Wang J; Sekulic A; Egan JB; Asmann YW; Kumar S; Maley C; Liu L
Bioinformatics; 2020 Mar; 36(6):1712-1717. PubMed ID: 32176769
[TBL] [Abstract][Full Text] [Related]
12. A novel network control model for identifying personalized driver genes in cancer.
Guo WF; Zhang SW; Zeng T; Li Y; Gao J; Chen L
PLoS Comput Biol; 2019 Nov; 15(11):e1007520. PubMed ID: 31765387
[TBL] [Abstract][Full Text] [Related]
13. Effects of Multi-Omics Characteristics on Identification of Driver Genes Using Machine Learning Algorithms.
Li F; Chu X; Dai L; Wang J; Liu J; Shang J
Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627101
[TBL] [Abstract][Full Text] [Related]
14. Somatic Mutational Profile of High-Grade Serous Ovarian Carcinoma and Triple-Negative Breast Carcinoma in Young and Elderly Patients: Similarities and Divergences.
Serio PAMP; de Lima Pereira GF; Katayama MLH; Roela RA; Maistro S; Folgueira MAAK
Cells; 2021 Dec; 10(12):. PubMed ID: 34944094
[TBL] [Abstract][Full Text] [Related]
15. A Graph Convolution Network-Based Model for Prioritizing Personalized Cancer Driver Genes of Individual Patients.
Peng W; Yu P; Dai W; Fu X; Liu L; Pan Y
IEEE Trans Nanobioscience; 2023 Oct; 22(4):744-754. PubMed ID: 37195839
[TBL] [Abstract][Full Text] [Related]
16. Integrating mutation and gene expression cross-sectional data to infer cancer progression.
Fleck JL; Pavel AB; Cassandras CG
BMC Syst Biol; 2016 Jan; 10():12. PubMed ID: 26810975
[TBL] [Abstract][Full Text] [Related]
17. Driver gene detection through Bayesian network integration of mutation and expression profiles.
Chen Z; Lu Y; Cao B; Zhang W; Edwards A; Zhang K
Bioinformatics; 2022 May; 38(10):2781-2790. PubMed ID: 35561191
[TBL] [Abstract][Full Text] [Related]
18. Protein Structure Readouts of Cancer Drivers for Precision Medicine.
Dhanjal JK; Kalra RS
Curr Protein Pept Sci; 2022; 23(3):158-165. PubMed ID: 35331108
[TBL] [Abstract][Full Text] [Related]
19. Discovering personalized driver mutation profiles of single samples in cancer by network control strategy.
Guo WF; Zhang SW; Liu LL; Liu F; Shi QQ; Zhang L; Tang Y; Zeng T; Chen L
Bioinformatics; 2018 Jun; 34(11):1893-1903. PubMed ID: 29329368
[TBL] [Abstract][Full Text] [Related]
20. Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population.
Huang Q; Zhou Y; Wang B; Zhao Y; Zhang F; Ding B
BMC Med Genomics; 2022 Jul; 15(1):146. PubMed ID: 35778737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
